[1]
Nidal Karim Al-Rahal, Oula Abdullah Najim, Ahmed Shemran Alwataify, Israa Mustafa Almusawi, Ahmed Ibrahim Shukr, Yaser Shanyor Alsalman 2022. Emicizumab Prophylaxis Every Four weeks among Hemophilia a with Inhibitors in Iraq, Multicenter Study. Journal for ReAttach Therapy and Developmental Diversities. 5, 2s (Dec. 2022), 477–482.